MHRA — authorised 16 November 2011
- Status: approved
MHRA authorised Vyndaqel on 16 November 2011
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MHRA authorised it on 16 November 2011.
Foldrx Pharms is the originator. The local marketing authorisation holder may differ — check the official source linked above.